000 | 01881 a2200529 4500 | ||
---|---|---|---|
005 | 20250517175743.0 | ||
264 | 0 | _c20171018 | |
008 | 201710s 0 0 eng d | ||
022 | _a1552-5783 | ||
024 | 7 |
_a10.1167/iovs.17-22000 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKitaoka, Yasushi | |
245 | 0 | 0 |
_aAxonal Protection by Ripasudil, a Rho Kinase Inhibitor, via Modulating Autophagy in TNF-Induced Optic Nerve Degeneration. _h[electronic resource] |
260 |
_bInvestigative ophthalmology & visual science _c10 2017 |
||
300 |
_a5056-5064 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAutophagy _xdrug effects |
650 | 0 | 4 |
_aAxons _xdrug effects |
650 | 0 | 4 | _aCell Count |
650 | 0 | 4 | _aCytoprotection |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aImmunoblotting |
650 | 0 | 4 | _aIntravitreal Injections |
650 | 0 | 4 |
_aIsoquinolines _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMicrotubule-Associated Proteins _xmetabolism |
650 | 0 | 4 |
_aNerve Degeneration _xmetabolism |
650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
650 | 0 | 4 |
_aOptic Nerve Diseases _xmetabolism |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aSequestosome-1 Protein _xmetabolism |
650 | 0 | 4 |
_aSulfonamides _xpharmacology |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xtoxicity |
650 | 0 | 4 | _aUp-Regulation |
650 | 0 | 4 |
_arho-Associated Kinases _xantagonists & inhibitors |
700 | 1 | _aSase, Kana | |
700 | 1 | _aTsukahara, Chihiro | |
700 | 1 | _aKojima, Kaori | |
700 | 1 | _aShiono, Akira | |
700 | 1 | _aKogo, Jiro | |
700 | 1 | _aTokuda, Naoto | |
700 | 1 | _aTakagi, Hitoshi | |
773 | 0 |
_tInvestigative ophthalmology & visual science _gvol. 58 _gno. 12 _gp. 5056-5064 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1167/iovs.17-22000 _zAvailable from publisher's website |
999 |
_c27633500 _d27633500 |